Northern Trust: Amedisys AMED Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Venta |
-290,933
| Cerradas | -USD 28.6 M | – | 4429 |
|
|
2025
Q2 | USD 28.6 M | Venta |
290,933
-9,734
| -3% | -USD 921 k | ﹤0.01% | 1438 |
|
|
2025
Q1 | USD 27.9 M | Compra |
300,667
+11,439
| +4% | +USD 1.05 M | ﹤0.01% | 1432 |
|
|
2024
Q4 | USD 26.3 M | Compra |
289,228
+55,264
| +24% | +USD 5.08 M | ﹤0.01% | 1515 |
|
|
2024
Q3 | USD 22.6 M | Venta |
233,964
-7,235
| -3% | -USD 706 k | ﹤0.01% | 1544 |
|
|
2024
Q2 | USD 22.1 M | Compra |
241,199
+30,803
| +15% | +USD 2.86 M | ﹤0.01% | 1490 |
|
|
2024
Q1 | USD 19.4 M | Venta |
210,396
-32,206
| -13% | -USD 3.02 M | ﹤0.01% | 1618 |
|
|
2023
Q4 | USD 23.1 M | Venta |
242,602
-3,632
| -1% | -USD 339 k | ﹤0.01% | 1516 |
|
|
2023
Q3 | USD 23 M | Venta |
246,234
-73,807
| -23% | -USD 6.82 M | ﹤0.01% | 1450 |
|
|
2023
Q2 | USD 29.3 M | Compra |
320,041
+10,334
| +3% | +USD 848 k | 0.01% | 1329 |
|
|
2023
Q1 | USD 22.8 M | Venta |
309,707
-289
| -0.1% | -USD 25 k | ﹤0.01% | 1474 |
|
|
2022
Q4 | USD 25.9 M | Venta |
309,996
-32,937
| -10% | -USD 2.97 M | 0.01% | 1378 |
|
|
2022
Q3 | USD 33.2 M | Venta |
342,933
-25,102
| -7% | -USD 2.99 M | 0.01% | 1128 |
|
|
2022
Q2 | USD 38.7 M | Venta |
368,035
-19,261
| -5% | -USD 2.46 M | 0.01% | 1050 |
|
|
2022
Q1 | USD 66.7 M | Compra |
387,296
+4,749
| +1% | +USD 709 k | 0.01% | 839 |
|
|
2021
Q4 | USD 61.9 M | Compra |
382,547
+36,972
| +11% | +USD 5.94 M | 0.01% | 952 |
|
|
2021
Q3 | USD 51.5 M | Compra |
345,575
+6,976
| +2% | +USD 1.45 M | 0.01% | 1052 |
|
|
2021
Q2 | USD 82.9 M | Venta |
338,599
-3,373
| -1% | -USD 885 k | 0.01% | 769 |
|
|
2021
Q1 | USD 90.6 M | Compra |
341,972
+43,363
| +15% | +USD 12.2 M | 0.02% | 722 |
|
|
2020
Q4 | USD 87.6 M | Compra |
298,609
+4,164
| +1% | +USD 1.07 M | 0.02% | 701 |
|
|
2020
Q3 | USD 69.6 M | Venta |
294,445
-9,716
| -3% | -USD 2.21 M | 0.02% | 719 |
|
|
2020
Q2 | USD 60.4 M | Venta |
304,161
-253,719
| -45% | -USD 47.3 M | 0.01% | 756 |
|
|
2020
Q1 | USD 102 M | Compra |
557,880
+2,624
| +0.5% | +USD 467 k | 0.03% | 468 |
|
|
2019
Q4 | USD 92.7 M | Venta |
555,256
-8,914
| -2% | -USD 1.33 M | 0.02% | 624 |
|
|
2019
Q3 | USD 73.9 M | Compra |
564,170
+61,310
| +12% | +USD 7.98 M | 0.02% | 691 |
|
|
2019
Q2 | USD 61.1 M | Compra |
502,860
+34,375
| +7% | +USD 4.08 M | 0.01% | 858 |
|
|
2019
Q1 | USD 57.7 M | Compra |
468,485
+87,399
| +23% | +USD 11 M | 0.01% | 856 |
|
|
2018
Q4 | USD 44.6 M | Venta |
381,086
-79,077
| -17% | -USD 9.32 M | 0.01% | 947 |
|
|
2018
Q3 | USD 57.5 M | Venta |
460,163
-30,650
| -6% | -USD 3.38 M | 0.01% | 897 |
|
|
2018
Q2 | USD 41.9 M | Venta |
490,813
-293,696
| -37% | -USD 21.6 M | 0.01% | 1171 |
|
|
2018
Q1 | USD 47.3 M | Venta |
784,509
-4,952
| -0.6% | -USD 282 k | 0.01% | 1034 |
|
|
2017
Q4 | USD 41.6 M | Venta |
789,461
-8,390
| -1% | -USD 442 k | 0.01% | 1128 |
|
|
2017
Q3 | USD 44.6 M | Venta |
797,851
-6,316
| -0.8% | -USD 334 k | 0.01% | 1046 |
|
|
2017
Q2 | USD 50.5 M | Compra |
804,167
+21,581
| +3% | +USD 1.26 M | 0.01% | 921 |
|
|
2017
Q1 | USD 40 M | Compra |
782,586
+9,179
| +1% | +USD 438 k | 0.01% | 1097 |
|
|
2016
Q4 | USD 33 M | Compra |
773,407
+8,341
| +1% | +USD 355 k | 0.01% | 1213 |
|
|
2016
Q3 | USD 36.3 M | Compra |
765,066
+8,700
| +1% | +USD 434 k | 0.01% | 1083 |
|
|
2016
Q2 | USD 38.2 M | Compra |
756,366
+2,113
| +0.3% | +USD 107 k | 0.01% | 997 |
|
|
2016
Q1 | USD 36.4 M | Compra |
754,253
+34,960
| +5% | +USD 1.35 M | 0.01% | 1026 |
|
|
2015
Q4 | USD 28.3 M | Venta |
719,293
-11,093
| -2% | -USD 444 k | 0.01% | 1219 |
|
|
2015
Q3 | USD 27.7 M | Compra |
730,386
+88,110
| +14% | +USD 3.72 M | 0.01% | 1247 |
|
|
2015
Q2 | USD 25.5 M | Venta |
642,276
-8,319
| -1% | -USD 259 k | 0.01% | 1388 |
|
|
2015
Q1 | USD 17.4 M | Compra |
650,595
+20,893
| +3% | +USD 589 k | 0.01% | 1685 |
|
|
2014
Q4 | USD 18.5 M | Venta |
629,702
-2,860
| -0.5% | -USD 70.6 k | 0.01% | 1600 |
|
|
2014
Q3 | USD 12.8 M | Venta |
632,562
-29,066
| -4% | -USD 561 k | ﹤0.01% | 1855 |
|
|
2014
Q2 | USD 11.1 M | Venta |
661,628
-42,904
| -6% | -USD 608 k | ﹤0.01% | 1968 |
|
|
2014
Q1 | USD 10.5 M | Venta |
704,532
-31,573
| -4% | -USD 486 k | ﹤0.01% | 2067 |
|
|
2013
Q4 | USD 10.8 M | Compra |
736,105
+18,761
| +3% | +USD 302 k | ﹤0.01% | 2042 |
|
|
2013
Q3 | USD 12.3 M | Compra |
717,344
+1,785
| +0.2% | +USD 26.5 k | ﹤0.01% | 1864 |
|
|
2013
Q2 | USD 8.3 M | Compra |
+715,559
| Nuevas | +USD 8.2 M | ﹤0.01% | 2052 |
|
Otros fondos que tienen AMED en su portafolio
Posición de Northern Trust en AMED: resumen de T3 2025
Northern Trust liquidó su posición en Amedisys (AMED) en T3 2025: cerró una participación de 290,933 acciones, con ventas por un valor estimado de USD 28.6 M.
Northern Trust reportó por primera vez una posición en AMED en T2 2013 y la mantuvo en 49 trimestres. La posición alcanzó su máximo de USD 102 M en T1 2020. Al cierre de T3 2025, 4 fondos que sigue Wall St. Rank mantienen una posición en AMED.
- Northern Trust reportó que ya no tenía una posición en Amedisys al cierre de T3 2025, después de venderla por completo durante el trimestre.
- Northern Trust vendió 290,933 acciones de Amedisys en T3 2025, por un valor estimado de USD 28.6 M.
- Northern Trust reportó por primera vez una posición en Amedisys en T2 2013 y la mantuvo en 49 trimestres.
- La posición de Northern Trust en Amedisys alcanzó su máximo de USD 102 M en T1 2020.
- Al cierre de T3 2025, 4 fondos que sigue Wall St. Rank tenían Amedisys en su portafolio.
Según el informe 13F de Northern Trust correspondiente a T3 2025, presentado el 14 nov 2025.